Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy
S. H. Kang; Y. B. Lee; J.‐H. Lee; J. Y. Nam; Y. Chang; H. Cho; J.‐J. Yoo; Y. Y. Cho; E. J. Cho; S. J. Yu; M. Y. Kim; Y. J. Kim; S. K. Baik; J.‐H. Yoon
Author Information: Department of Internal Medicine and Liver Research Institute
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.